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Members of the genus Brucella are known worldwide as pathogens of wildlife and livestock and are the most
common organisms of zoonotic infection in humans. In general, brucellae exhibit a range of host specificity in
animals that has led to the identification of at least seven Brucella species. The genomes of the various Brucella
species are highly conserved, which makes the differentiation of species highly challenging. However, we found
single-nucleotide polymorphisms (SNPs) in housekeeping and other genes that differentiated the seven main
Brucella species or clades and thus enabled us to develop real-time PCR assays based around these SNPs.
Screening of a diverse panel of 338 diverse isolates with these assays correctly identified each isolate with its
previously determined Brucella clade. Six of the seven clade-specific assays detected DNA concentrations of less
than 10 fg, indicating a high level of sensitivity. This SNP-based approach places samples into a phylogenetic
framework, allowing reliable comparisons to be made among the lineages of clonal bacteria and providing a
solid basis for genotyping. These PCR assays provide a rapid and highly sensitive method of differentiating the
major Brucella groups that will be valuable for clinical and forensic applications.
Brucella spp. are pathogenic bacteria that infect a wide va-
riety of mammalian hosts worldwide, often causing reproduc-
tive failure. The genus Brucella has classically been divided into
six species based on host specificity, including B. abortus (cattle
and bison), B. melitensis (goats and sheep), B. suis (pigs), B.
canis (dogs), B. neotomae (desert woodrat), and B. ovis (sheep)
(12). Two new species have been discovered recently in marine
mammals (B. cetaceae in dolphins and whales and B. pinnipe-
diae in seals) (10). Taxonomic limits of the marine clade, how-
ever, are not fully defined, and this group may represent one to
three species (8, 18). B. abortus, B. melitensis, B. suis, and B.
canis are well-characterized zoonotic pathogens, annually in-
fecting 500,000 people worldwide (26). In the United States,
the first three of these species are defined as select agents due
to their pathogenicity and potential use as biological weapons
(11).
Despite host-based segregation, Brucella spp. have proven
challenging to differentiate using molecular techniques. Bru-
cella genomes are highly conserved, with 90% homology
among species based on DNA-DNA hybridization (35), iden-
tical 16S rRNA sequences among all species (15), and 90%
of genes sharing 98% sequence identity (16, 27). Serological
methods and biochemical testing of isolates allow differentia-
tion of species and biovars. However, PCR-based methods
have been used increasingly due to their accuracy, sensitivity,
and speed of identification and the ability to work with DNA as
opposed to highly infectious live cultures. A wide array of
genetic polymorphisms can be assayed for the differentiation of
Brucella spp., including the insertion element IS711 (2, 3, 29,
31) and genes of outer membrane proteins (7, 10, 20), and
other assay techniques may be used, such as whole-gene dif-
ferentiation (30), infrequent restriction site PCR (6), and am-
plified fragment length polymorphisms (37). PCR-based assays
for identifying Brucella were recently reviewed (1).
Improved resolution among Brucella isolates for the pur-
poses of genotyping and epidemiology has been obtained by
using more rapidly evolving markers. For example, variable-
number tandem repeats (VNTR) incorporated into multilocus
VNTR analysis (MLVA) successfully differentiate even closely
related isolates and provide fairly accurate species-level reso-
lution (1a, 17, 21, 39). Rapidly evolving VNTR markers often
suffer from homoplasy, i.e., the appearance of the same genetic
alteration in two or more branches of a phylogenetic tree.
These phenomena can disrupt and confound the accurate phy-
logenetic placement of all isolates within a single MLVA tree
and prevent the accurate species-level designation of some
isolates.
For distinguishing bacteria with clonally derived population
structures (such as Brucella [38]), single-nucleotide polymor-
phisms (SNPs) can be used to accurately describe the phylo-
genetic framework of a species (28, 33). SNPs can be discov-
ered through either whole-genome comparisons or multilocus
sequence typing (MLST) of housekeeping genes. In Brucella,
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these stable and slowly evolving markers provide the initial
resolution within taxonomic trees. A nested hierarchical ap-
proach involving SNP analysis to define the major branches,
followed by analysis using more rapidly evolving VNTR mark-
ers, will generate unambiguous differentiation of isolates into
major clades, with maximum resolution at the individual iso-
late level (19). SNP-based differentiation of clades can then be
incorporated into real-time PCR assays, providing a quick
method for determining specific groupings (23, 32, 34).
We discovered SNPs that use nucleotide sequences from
housekeeping genes and published gene sequences, and we
developed real-time PCR assays to identify the seven main
Brucella species. These TaqMan assays contained probes spe-
cific to each allele and were screened against a large and
diverse collection. Our assays provide a reliable and rapid
method for the identification of Brucella species that can
readily be incorporated into clinical, forensic, or evolutionary
applications.
MATERIALS AND METHODS
SNP discovery. To identify species-specific SNPs for the development of real-
time PCR assays, we initially selected five housekeeping gene products: the ABC
(abc) transporter ATP-binding protein, shikimate 5-dehydrogenase and shiki-
mate dehydrogenase (aroE and gdh) family proteins, and the chaperonin
(groEL), proline iminopeptidase (pip), and sulfate ABC transporter (cysW) pro-
teins. Our primary goal was not to run a full MLST analysis but to find suitable
SNPs for species differentiation. We also utilized SNPs in genes coding for an
outer membrane protein (omp25), the RNA polymerase beta-subunit (rpoB), and
the anthranilate synthase (trpE) (polymorphisms previously described in refer-
ences 22, 36, and 38, respectively). We designed PCR primers to amplify a
portion of each gene (Table 1).
Cellular DNAs were extracted using heat soaks or genomic preparations and
were diluted to roughly 0.1 to 1 ng/l for assay screening. We amplified frag-
ments in 10-l PCR mixtures consisting of 1 PCR buffer, 2.8 mM MgCl2, 0.6
M of each primer, 0.8 mM of each deoxynucleotide triphosphate, and 1 U of
Platinum Taq (Invitrogen, Carlsbad, CA). We used the following cycling profile
at 94°C for 5 min: 30 cycles of denaturation at 94°C for 30 s, annealing at 62°C
for 30 s, and extension at 72°C for 1 min, with a final extension of 72°C for 7 min.
We cycle sequenced 1 l of product in a 10-l reaction mixture with Applied
Biosystems Big Dye 3.1 and then purified with 2.5 l of 125 mM EDTA and
followed with washes of 100% and 70% ethanol. Sequences were run on an AB
3730 model automated sequencer. We edited and aligned sequences using
SEQUENCHER 4.6 software (Gene Codes Corporation, Ann Arbor, MI). Se-
quences were then compared in silico to those of whole-genome sequences from
GenBank or unpublished sources from B. abortus 2308 (4), B. abortus 9-941 (16),
B. melitensis 16 M (13), B. suis 1330 (27), B. ovis 63/290 (The Institute for
Genomic Research accession numbers CP000708 and CP000709), and B. canis
RM6/66 (Los Alamos National Laboratory, NM).
Real-time PCR development. Real-time PCR assays were developed with six
genes, containing species-specific SNPs: abc, cysW, omp25, pip, rpoB, and trpE.
We designed primers and probes with Primer Express TaqMan minor groove
binding (MGB) for Allelic Discrimination version 3.0 (Applied Biosystems, Fos-
ter City, CA) software. Primers amplified the region containing the SNP, which
binds to either of the two probes for the specific allele of the SNP state (Table
2). Assays were run on an ABI Prism 7900HT sequence detection system (Ap-
plied Biosystems). Each 10-l PCR mixture contained 1 TaqMan Universal
master mixture (Applied Biosystems), 0.9 M of each primer, and 0.2 M of
each probe. In addition, 0.2 U of Platinum Taq (Invitrogen) per reaction mixture
was added to increase the efficiency of the amplification, except for the rpoB
assay, which used 0.25 U of Platinum Taq. For the trpE assay, the PCR was
slightly modified to reduce amplification of the nonmarine mammal probe. The
quantity of the probes was set to 0.06 M of probe 1 (using 6-carboxyfluorescein
[FAM] dye) and 0.14 M of probe 2 (using VIC dye) to optimize the reaction.
We ran each assay under standard conditions consisting of a 2-min inactivation
at 50°C and a 10-min hot start at 95°C, followed by 40 cycles of a 15-s denatur-
ation and 1 min of annealing at 60°C.
We tested the limits and sensitivity of each assay, using serial 10-fold dilutions.
Starting at a concentration of 1 ng/l, we progressively diluted down to 1 fg/l.
Each sample was run in duplicate, and five samples were tested for each assay.
We also quantified the efficiency of the reaction at 1 ng/l with these 10 samples,
as expressed by the cycle threshold values. DNA concentrations were quantified
by UV spectroscopy by NanoDrop spectrophotometer (NanoDrop Technologies,
Wilmington, DE) and PicoGreen assays (Molecular Probes, Eugene, OR).
Brucella DNA samples. We screened a diverse collection of 338 Brucella DNA
samples for each assay. These samples included 165 isolates of B. melitensis, 85
isolates of B. abortus, 53 isolates of B. suis, 11 marine mammal isolates (from eight
seals and three dolphins), 10 isolates of B. canis, 8 isolates of B. ovis, and 6 isolates
of B. neotomae (Table 3). Samples were known to contain all recognized biovars
except for B. abortus biovar 3 and B. suis biovars 3 and 5. We also included four
samples from Ochrobactrum anthropi, a closely related soil bacterium, to test the
specificity of the assays. All Brucella samples had initially been identified using
phenotypic, biochemical, and serological tests, including tests such as Gram stain
morphology, lack of motility, oxidase positivity, and agglutination in Brucella anti-
serum (5). Over 75% of the samples had also undergone PCR testing for species
designation by following procedures described in reference 3.
Nucleotide sequence accession numbers. We deposited all sequences in
GenBank under accession numbers EU001373 to EU001657.
RESULTS
SNP identification. We compared sequences for the pres-
ence of six housekeeping genes for at least 36 isolates across all
seven Brucella species. Nineteen SNPs were identified, includ-
ing four specific to B. abortus, three for B. canis/B. suis, two for
B. ovis and one for B. melitensis. Four of these SNPs were
developed into species-specific assays for each species/clade,
including two SNPs in the abc gene and two SNPs in the cysW
gene. Additional genes were necessary for species-specific as-
says for B. canis, B. neotomae, and the marine mammal clade.
No SNPs were found that defined B. suis exclusively.
Allelic discrimination and assay screening. All seven SNP
assays correctly identified all samples (n  338) belonging to
the appropriate species. However, one sample we believe con-
tained mixed DNA, although we did not have the cell culture
to test this hypothesis. In this instance, both species-specific (B.
TABLE 1. Primers used to amplify portions of housekeeping genes and other loci in Brucella
Gene Forward primer (5–3) Reverse primer (5–3) Fragment size (bp)
abc TAGGCCGAATAATTGCCTTC GACCGCTACAACGAGCTGAT 419
aroE ATGGAAGGCAAGATCGTCAA CTGGCACAGTTCGTCAACAG 498
cysW CTTCCCTGCACTTCCATCAG ACCAATCTCATCCAGGCAAG 546
gdh GATGGTGTCGGTTTTGTGC GATATGCTGGTGCATTGTGG 557
groEL CTGGACGACAGCTTCGAGA GGCTTCCAAGACCAACGATA 485
pip CGGTCAGGCGCTTGTAAT CGCATTCATGTCGAGCAAT 484
omp25 TGGTGGCTATACCGGTCTTT AGGATGTTGTCCGTCAGCTT 384
omp25 AAGTCAAGCAGGGCTTTGAA ACCGGATGCCTGAAATCCTTa 395
a Same primer designated as 25B and used by Cloeckaert et al. (9). A portion of the omp25 gene was sequenced with two overlapping primer sets. The fragment size
is approximate due to a tandem repeat at the 3 end of the sequence.
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melitensis and B. suis/B. canis) assays indicated a mixed sample,
with both alleles amplifying almost equally, suggesting equal
amounts of DNA from the corresponding species. We identi-
fied the correct species/clade of 11 blind samples and 6 incor-
rectly labeled samples whose identities were discovered only
after the analyses. These samples were identified with their
species by conventional biochemical testing and/or were as-
signed to species by MLVA (17).
Six of the seven assays exhibited rapid amplification of the
allele containing the corresponding SNP, with the alternate
allele either failing to amplify or weakly amplifying (Table 4).
Amplification of the alternate allele above the minimum cycle
threshold (CT) value occurred only in the assays for B. abortus
and marine mammals. The difference in the CT values between
probes (CT) in the B. abortus assay was 12.3 (n  8), provid-
ing easy differentiation. In our initial screening of the marine
mammal assay, using standard probe concentrations (0. 9 M,
each probe), the allele for nonmarine mammal samples rapidly
amplified at a CT value of 20.2  0.9 (n  5), and the alternate
allele was not detected when nonmarine mammal samples
were run. However, cross-hybridization of probes occurred
when marine mammal samples were run (CT 1.6). Thus, we
optimized probe concentrations to improve the differentiation
of alleles. When the altered concentrations were used with the
marine mammal assay, the CT was 4.7 between the primary
and the alternate probes for marine mammals and 9.9 for
samples from nonmarine mammals (n  14).
All assays detected at least one sample with a DNA concen-
TABLE 2. Oligonucleotide sequences for primers and TaqMan MGB probes for Brucella clade identification
SNP clade Assay name Primers (5–3) Probes (5–3)a Genome positionb SNP identityc
B. abortus abc_205 F-GTTTCCGCATCCAAAT
GGTT
FAM-AAGCAGAATCTTG
CACA
573136 T, B. abortus
R-TTCGGGCGGTGAAAAGC VIC-AAAGCAGAAGCTTG G, other spp.
B. suis/B. canis abc_246 F-AGCCTGACCTGCTGCT
TCTC
FAM-ATGAGCCCACCAAC 573177 C, B. suis/B. canis
R-GAGCCAGGCTGTGGT
TTCC
VIC-ATGAGCCGACCAAC G, other spp.
B. ovis cysW_234 F-CCGGGAAAGCGGAATTTC VIC-CGAAAGCGATGT
TGAT
696894 G, B. ovis
R-GCTGACCGCAATCGT
TGTC
FAM-CGAAAGCCATGT
TGAT
C, other spp.
B. melitensis cysW_288 F-GGAAAAAGGTATCTCCAC
GAAGGT
VIC-AGCCTGCGTCCGGG 696948 G, B. melitensis
R-CGTGGCTGGTGACGA
AATT
FAM-TGAGGAGCCTTCG T, other spp.
B. canis omp25_256 F-GGCTGGCGCCTTTGCT FAM-AACTTCCAGAA
GGAC
1297911 A, B. canis
R-GGCCCAGGAATAACCT
GCAT
VIC-ACTTCCAGCAGGACC C, other spp.
B. neotomae rpoB_2673 F-CATCCTGGCGACATTCT
TGTC
VIC-AAGATCACGCCG
AAGG
776263 G, B. neotomae
R-GGCGTCATCGGGCTTTC FAM-TCACGCCTAAGGG T, other spp.
Marine mammals trpE_290 F-ACGAGGATTCCTTCGTCC
ATAC
FAM-CCAATTATTTCCACC
AGAC
468289 A, marine mammal
R-AACGCACGGTGGAAA
CCTT
VIC-TTGCCAATTATTTCC
GCCA
G, other spp.
a TaqMan probes with a minor groove binder (MGB). Each probe was fluorescently labeled with either VIC or FAM dye.
b Based on the genome of B. melitensis 16M chromosome I (GenBank accession no. AE008917).
c The SNP identities are listed for the primer letters in bold.
TABLE 3. Brucella species isolates used in screening assaysa
Species
No. of isolates of indicated biovar or strek
Total
1 2 3 4 5 6 7 9 Typestrain None
B. abortus 41 2 2 4 2 1 1 1 2 29 85
B. canis 1 9 10
B. melitensis 49 15 20 1 80 165
B. neotomae 2 4 6
B. ovis 1 7 8
B. suis 28 1 4 1 19 53
Marine mammal 11 11
a Brucella species isolates (n  338) used to screen assays are shown. The
biovar is given when available.
TABLE 4. Cycle threshold values and detection concentrations for
seven Brucella species assaysa
SNP clade Assay name
CT value  SD Detection
concn
(fg/l)bAllele 1 Allele 2
B. abortus abc_205 21.1  1.4 19.5  0.8 10
B. suis/B. canis abc_246 19.3  1.1 20.1  0.9 10
B. ovis cysW_234 17.5  1.3 18.4  1.3 10
B. melitensis cysW_288 20.9  0.1 21.2  0.5 10
B. canis omp25_256 19.3  0.7 19.2  1.1 10
B. neotomae rpoB_2673 21.3  0.1 26.3  1.2 100
Marine mammals trpE_290 20.2  0.9 21.2  0.2 10
a CT values  standard deviations and detection concentrations are shown for
seven Brucella species assays. CT values are from assays run at a concentration of
1 ng/l (n  8 to 10 isolates).
b We considered the positive detection of a sample when the majority of
samples successfully amplified within 40 cycles. For the marine mammal assay,
detection concentrations were assessed at standard (equal) probe concentra-
tions.
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tration of less than 10 fg/l, with reliable amplification for all
assays at 100 fg/l and greater (Fig. 1). In fact, the majority of
samples at a concentration of 1 fg/l were successfully ampli-
fied in six of the seven assays (the assay for B. neotomae was
less sensitive). In every instance, the amplification was clearly
distinguishable from the no-template controls. Samples from
the closely related soil bacterium Ochrobactrum anthropi failed
to amplify in five of the seven assays. In the B. abortus assay
(abc_205), the alternate allele (i.e., all non-B. abortus samples)
amplified strongly, and in the B. neotomae assay (rpoB_2673),
the alternate allele amplified weakly.
DISCUSSION
The taxonomic description of the Brucella species has been
accomplished using a broad range of microbiological and mo-
lecular approaches. In a clinical setting, working with Brucella
requires the handling of highly infectious agents, expertise with
culturing bacteria on a variety of media, and at least 5 to 7 days
under standard microbiological practices. Current molecular ge-
netic techniques for species-level identification are technically
challenging and/or are limited to only a few species. Thus, devel-
opment of quick and reliable methods for identifying Brucella
species from limited amounts of DNA is crucial for today’s clin-
ical and epidemiological applications. Furthermore, determina-
tion of the Brucella species will allow implementation of appro-
priate public health interventions in a timely manner.
Our real-time PCR assays provide rapid identification of the
seven major Brucella clades: B. abortus, B. melitensis, B. canis,
B. suis/B. canis, B. neotomae, B. ovis, and Brucella in marine
mammals. SNPs defining B. suis exclusively have yet to be
found, but this species can be identified using the B. suis/B.
canis assay to assign a sample to this clade and a B. canis assay
to rule out that it is B. canis. Each assay that we have presented
is binary within the Brucella genus; that is, either the sample is
in a particular Brucella clade or it is one of the other Brucella
species. One of the closest known relatives, Ochrobactrum an-
thropi, served as a good negative control and never amplified as
the primary allele in any assay. Although the strains used were
biochemically similar to those of other fastidious gram-nega-
tive coccobacilli, such as Bordetella bronchiseptica, Oligella
ureolytica, or other Brucella “mimics” (5), GenBank BLAST
searches of the real-time PCR sequences failed to produce
significant homology to any genus besides Brucella. Thus, it is
very unlikely that broader specificity testing with other bacteria
would amplify the primary allele in any of the assays.
FIG. 1. Real-time PCR and allelic discrimination plots from TaqMan MGB assays for an SNP defining Brucella melitensis. Ten samples (4 B.
melitensis and 6 other Brucella species samples) were run at concentrations decreasing from 1 ng/l to 1 fg/l. (A) Amplification curves for B.
melitensis samples run in duplicate. (B) Allelic discrimination plots for all samples. Samples at the top left are B. melitensis and at the bottom right
are other Brucella spp., and at the bottom left, squares near the plot origin are no-template controls (NTCs; n 8). Numbers on the axes represent
degrees of differentiation of points and are based on the threshold values of the reactions.
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The consistent sensitivity of the assays at 10 fg/l or less
represents detection of less than three genome equivalents of
DNA. In fact, most of our assays detected DNA at concentra-
tions of 1 fg/l (less than a genome’s equivalent), which is close
to the theoretical limit of detection. Similar results have been
achieved with B. abortus assays with detections of roughly two
genome copies of DNA (25). At extremely low concentrations
of DNA, a failure of at least 37% of reactions is expected based
on Poisson statistics and the likelihood of sampling error (14).
Low-level detectability is essential for forensic applications, as
well as for environmental sampling and clinical detection. De-
tecting minute quantities in blood is important for clinical work
relating to Brucella infections, where small amounts of bacteria
may be circulating in the blood. Diagnostic PCR assays from
blood must deal with PCR inhibitors such as heme and/or
leukocyte DNA, but this can be alleviated through specific lysis
and washing procedures (24). We believe our assays can be
modified and incorporated into clinical tests to detect and
subtype Brucella DNAs from human or animal blood samples.
Because a false negative could have serious consequences re-
garding laboratory exposure, when running our assays to test
for the presence of Brucella, a 16S rRNA control should be
included to confirm the presence of bacterial DNA.
Sequencing of whole genomes, housekeeping genes for
MLST, and specific other loci have provided the SNPs neces-
sary for the differentiation of various Brucella species. To in-
crease our confidence that the SNPs chosen could accurately
place each isolate into its appropriate species or clade, assays
were tested against a large and diverse collection of 338 iso-
lates. Each additional sample that is screened increases the
confidence in the assay. Providing that the assays successfully
amplify each allele with minimal cross-hybridization of probes,
SNP-based real-time PCR assays are a very reliable method for
differentiating species. The conserved distribution of the SNPs
used in this study with a relatively large collection of diverse
Brucella subtypes suggests that these sites are nonhomoplastic.
This idea is supported by previous studies that indicate sparse
mutation density and rare recombination events and suggests a
primary clonal population structure for brucellae (16, 27, 38).
The conserved Brucella phylogeny is reminiscent of the exten-
sively characterized Bacillus anthracis genome, the status of
1,000 SNPs in 27 diverse isolates revealed only a single homo-
plastic event (33). A more definitive estimate of the extent of
homoplasy in Brucella organisms can eventually be obtained by
similar comparative genomic analysis and SNP discovery in the
Brucella genomes. The hypothesis that a limited number of
SNPs (canonical SNPs) along a conserved phylogenetic branch
can represent a large subset of SNPs in B. anthracis (19, 28, 33)
appears to be similar to the scenario for Brucella, for which
limited but powerful SNP-based assays provide a strong phy-
logenetic framework and, combined with MLVA, provide a
highly resolved genotyping scheme across a broad spectrum of
isolates. Again, SNPs resolve the major Brucella species, and
MLVA provides finer-scale resolution and genotyping that can
be used for epidemiological purposes (1a).
Our samples may or may not have contained isolates from
the biovars B. abortus biovar 3 (Tulya) and B. suis biovars 3 and
5. Of these, B. suis biovar 5 represents the most likely challenge
to our B. suis/B. canis assay because strong differentiation of
this biovar from other B. suis species has been shown by both
MLVA (21, 39) and MLST (38). These papers also suggest that
B. suis is the most diverse clade within the Brucella genus.
Furthermore, finding SNPs that separate B. canis from B. suis
is challenging due to a high degree of sequence homology that
indicates a recent split between these species.
In conclusion, we present an efficient method of determining
all currently recognized Brucella species that should have
broad clinical and forensic applications. Furthermore, samples
can be distinguished near the limits of detection. Multiplexing
of reactions appears possible in the future so that discrimina-
tion of Brucella can be achieved with one test. Nonetheless, in
many areas of the world, the Brucella species that cause infec-
tion are likely known, and this test will rapidly confirm species
identification.
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ERRATUM
Real-Time PCR Assays of Single-Nucleotide Polymorphisms Defining the Major
Brucella Clades
Jeffrey T. Foster, Richard T. Okinaka, Rita Svensson, Kathryn Shaw, Barun K. De,
Richard A. Robison, William S. Probert, Leo J. Kenefic,
William D. Brown, and Paul Keim
Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, Arizona 86011-5640; Bioscience Division,
Los Alamos National Laboratory, Los Alamos, New Mexico 87545; Centers for Disease Control and Prevention,
Atlanta, Georgia 30333; Department of Microbiology and Molecular Biology, Brigham Young University, Provo,
Utah 84602; and Microbial Diseases Laboratory, California Department of
Public Health, Richmond, California 94804
Vol. 46, no. 1, p. 296–301, 2008. Page 298, Table 2, column 6, line 12: “G, B. melitensis” should read “G, other spp.”
Page 298, Table 2, column 6, line 14: “T, other spp.” should read “T, B. melitensis.”
Page 298, Table 3, spanner over columns 2 to 11: “No. of isolates of indicated biovar or strek” should read “No. of isolates of
indicated biovar or strain.”
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